Cargando…
European follow-up of incorrect biomarker results for colorectal cancer demonstrates the importance of quality improvement projects
Biomarker analysis for colorectal cancer has been shown to be reliable in Europe with 97% of samples tested by EQA participants to be correctly classified. This study focuses on errors during the annual EQA assessment. The aim was to explore the causes and actions related to the observed errors and...
Autores principales: | Keppens, Cleo, Dufraing, Kelly, van Krieken, Han J., Siebers, Albert G., Kafatos, George, Lowe, Kimberly, Demonty, Gaston, Dequeker, Elisabeth M. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611891/ https://www.ncbi.nlm.nih.gov/pubmed/30719547 http://dx.doi.org/10.1007/s00428-019-02525-9 |
Ejemplares similares
-
Variation in nomenclature of somatic variants for selection of oncological therapies: Can we reach a consensus soon?
por: Keppens, Cleo, et al.
Publicado: (2019) -
Managing Deviating EQA Results: A Survey to Assess the Corrective and Preventive Actions of Medical Laboratories Testing for Oncological Biomarkers
por: Keppens, Cleo, et al.
Publicado: (2020) -
Accreditation, setting and experience as indicators to
assure quality in oncology biomarker testing laboratories
por: Tack, Véronique, et al.
Publicado: (2018) -
Causes behind error rates for predictive biomarker testing: the utility of sending post-EQA surveys
por: Keppens, Cleo, et al.
Publicado: (2020) -
The Healthcare Professionals’ Perspective on Impact and Actions Taken Following Severe Infusion Reaction Events in Oncology Centers in Europe
por: Kafatos, George, et al.
Publicado: (2020)